News
UnitedHealth is reviewing four bids for its Latin American unit Banmedica, aiming to finalize a sale amid financial setbacks ...
UnitedHealth Group (NYSE: UNH) and Humana (NYSE: HUM) are pushing to increase oversight and limit payments to insurers for in-home clinical assessments in ...
A return of a former CEO and questions about its Medicare Advantage pricing dominate the outlook for this formerly ...
With a price target of $377, analysts from the Bernstein SocGen Group reiterated their Outperform rating on UnitedHealth ...
Humana has told congressional staffers that it will support moves that would curtail billing practices worth billions in ...
UnitedHealth Group (NYSE: UNH) signaled confidence in its merger with Amedisys (Nasdaq: AMED) in a document prepared for shareholders. An earlier draft of ...
UnitedHealth stock has crashed some 50% amidst a cascade of bad news. Cavenagh Research says UNH shares could tumble further.
Piper Sandler sharply lowered its price target on UnitedHealth Group Incorporated (NYSE:UNH) to $353 from $552, while ...
6d
Zacks Investment Research on MSNUnitedHealth to Curtail Medicare Advantage Costs: Margin Boost Ahead?UnitedHealth Group Incorporated’s UNH new CEO, Steve Hemsley, began his return to leadership by issuing a rare apology to ...
UnitedHealth Group faces short-term challenges, but strong fundamentals, undervaluation, and long-term growth potential make ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results